{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:26:11Z","timestamp":1790871971504,"version":"4.1.0"},"reference-count":40,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2020.8612","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T09:05:17Z","timestamp":1584608717000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR\u2011tyrosine kinase inhibitor treatment in patients with non\u2011small cell lung cancer from different ethnic groups"],"prefix":"10.3892","author":[{"given":"Qiao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Thoracic Oncology, The Third Clinical Medical College of Xinjiang Medical University, The Affiliated Tumor Hospital Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Geriatric, The First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi, Xinjiang 832000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Outpatient Department, People's Liberation Army 69260 Troops of Medical Team, Urumqi, Xinjiang 830002, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayideng","family":"Kenjiabieke","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, The Third Clinical Medical College of Xinjiang Medical University, The Affiliated Tumor Hospital Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patiguli","family":"Aerxiding","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, The Third Clinical Medical College of Xinjiang Medical University, The Affiliated Tumor Hospital Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"key20200713010431_b1-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"key20200713010431_b2-etm-0-0-8612","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1158\/1538-7445.AM2017-4859","article-title":"Abstract 4859: The role of LPAR1 and fibrosis in breast cancer metastasis","volume":"77","author":"Brooks","year":"2017","journal-title":"Cancer Res"},{"key":"key20200713010431_b3-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3779\/j.issn.1009-3419.2006.02.17","article-title":"Study on relationship between VEGF-C and lymphangiogenesis and lymph node metastasis in non-small cell lung cancer","volume":"9","author":"Wang","year":"2006","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"key20200713010431_b4-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713010431_b5-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20200713010431_b6-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"key20200713010431_b7-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/JTO.0b013e3182582a93","article-title":"Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure","volume":"7","author":"Arrieta","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20200713010431_b8-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1097\/JTO.0b013e31822f655f","article-title":"Genotyping non-small cell lung cancer (NSCLC) in Latin America","volume":"6","author":"Arrieta","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20200713010431_b9-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1148\/radiol.13112553","article-title":"Epidermal growth factor receptor mutation in lung adenocarcinomas: Relationship with CT characteristics and histologic subtypes","volume":"268","author":"Lee","year":"2013","journal-title":"Radiology"},{"key":"key20200713010431_b10-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/OTT.S41797","article-title":"Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation","volume":"6","author":"Yamane","year":"2013","journal-title":"Onco Targets Ther"},{"key":"key20200713010431_b11-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713010431_b12-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/dji055","article-title":"Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers","volume":"97","author":"Shigematsu","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key20200713010431_b13-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.bjc.6604068","article-title":"\u2018Classical\u2019 but not \u2018other\u2019 mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer","volume":"97","author":"Pallis","year":"2007","journal-title":"Br J Cancer"},{"key":"key20200713010431_b14-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"32626","DOI":"10.18632\/oncotarget.15945","article-title":"Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations","volume":"8","author":"Frega","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713010431_b15-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lungcan.2016.01.018","article-title":"EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China","volume":"96","author":"Xu","year":"2016","journal-title":"Lung Cancer"},{"key":"key20200713010431_b16-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.2147\/OTT.S108242","article-title":"Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20200713010431_b17-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/bjc.2016.372","article-title":"Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment","volume":"115","author":"Kuiper","year":"2016","journal-title":"Br J Cancer"},{"key":"key20200713010431_b18-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/1759-7714.12568","article-title":"Comparison of therapeutic effects of EGFR-tyrosine kinase inhibitors on 19Del and L858R mutations in advanced lung adenocarcinoma and effect on cellular immune function","volume":"9","author":"Zhou","year":"2018","journal-title":"Thoracic Cancer"},{"key":"key20200713010431_b19-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3892\/or.2013.2298","article-title":"Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells","volume":"29","author":"Li","year":"2013","journal-title":"Oncol Rep"},{"key":"key20200713010431_b20-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10147-012-0515-4","article-title":"Frequency of epidermal growth factor receptor mutations in Bangladeshi patients with adenocarcinoma of the lung","volume":"19","author":"Rahman","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"key20200713010431_b21-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s13402-012-0078-4","article-title":"EGFR and KRAS mutations in lung carcinomas in the Dutch population: Increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma","volume":"35","author":"Smits","year":"2012","journal-title":"Cell Oncol (Dodr)"},{"key":"key20200713010431_b22-etm-0-0-8612"},{"key":"key20200713010431_b23-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th edition of the AJCC Cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20200713010431_b24-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/pl00011706","article-title":"Significance of and problems in adopting response evaluation criteria in solid tumor RECIST for assessing anticancer effects of advanced gastric cancer","volume":"3","author":"Yoshida","year":"2000","journal-title":"Gastric Cancer"},{"key":"key20200713010431_b25-etm-0-0-8612","doi-asserted-by":"crossref","first-page":"57","DOI":"10.18388\/abp.2013_1951","article-title":"ARMS-PCR for detection of BRAF V600E hotspot mutation in comparison with Real-Time PCR-based techniques","volume":"60","author":"Machnicki","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"key20200713010431_b26-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.3892\/or.2013.2709","article-title":"Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer","volume":"30","author":"Chu","year":"2013","journal-title":"Oncol Rep"},{"key":"key20200713010431_b27-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/or.7.3.603","article-title":"Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression","volume":"7","author":"Ohsaki","year":"2000","journal-title":"Oncol Rep"},{"key":"key20200713010431_b28-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/s0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37 (Suppl 4)","author":"Nicholson","year":"2001","journal-title":"Eur J Cancer"},{"key":"key20200713010431_b29-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"key20200713010431_b30-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrc2088","article-title":"Epidermal growth factor receptor mutations in lung cancer","volume":"7","author":"Sharma","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20200713010431_b31-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/JTO.0b013e3182781e35","article-title":"Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors","volume":"8","author":"Kobayashi","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"1967","key":"key20200713010431_b32-etm-0-0-8612","article-title":"EGFR mutations in patients with non-small cell lung cancer from mainland China and their relationships with clinicopathological features: A meta-analysis","volume":"7","author":"Wang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"key20200713010431_b33-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.lungcan.2009.04.011","article-title":"EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer","volume":"67","author":"Wu","year":"2010","journal-title":"Lung Cancer"},{"key":"key20200713010431_b34-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6602707","article-title":"Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma","volume":"93","author":"Sonobe","year":"2005","journal-title":"Br J Cancer"},{"key":"key20200713010431_b35-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity","volume":"11","author":"Yun","year":"2007","journal-title":"Cancer Cell"},{"key":"key20200713010431_b36-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/JTO.0000000000000504","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced lung adenocarcinomas with G719X\/L861Q\/S768I mutations","volume":"10","author":"Chiu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"key20200713010431_b37-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-10-3408","article-title":"Effectiveness of tyrosine kinase inhibitors on \u2018uncommon\u2019 epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20200713010431_b38-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","article-title":"Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer","volume":"277","author":"Mitsudomi","year":"2010","journal-title":"FEBS J"},{"key":"key20200713010431_b39-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1158\/1078-0432.CCR-14-0846","article-title":"Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation","volume":"21","author":"Yoshida","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20200713010431_b40-etm-0-0-8612","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/JTO.0000000000000048","article-title":"Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q","volume":"9","author":"Watanabe","year":"2014","journal-title":"J Thorac Oncol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T05:11:17Z","timestamp":1666156277000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2020.8612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3892\/etm.2020.8612","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}